Blood Pressure Management in Stroke
Acute Intracerebral Hemorrhage (ICH)
For spontaneous ICH with systolic BP 150-220 mmHg, immediately initiate intensive BP lowering to achieve a target of 130-150 mmHg (specifically targeting 140 mmHg systolic), starting within 2 hours of onset and reaching target within 1 hour. 1
Key Management Principles for ICH:
- Target range: Systolic BP 130-150 mmHg is safe and may improve functional outcomes 1
- Timing is critical: Begin treatment within 2 hours of ICH onset to reduce hematoma expansion risk 1
- Avoid aggressive lowering: Do NOT lower systolic BP below 130 mmHg—this is potentially harmful 1
- Smooth titration: Use continuous IV infusion (not boluses) to avoid BP variability, which independently worsens outcomes 1
Preferred Agents for ICH:
- Nicardipine 5 mg/h IV, titrate by 2.5 mg/h every 5-15 minutes (max 15 mg/h)
- Clevidipine 1-2 mg/h IV, double dose every 2-5 minutes (max 21 mg/h)
- Labetalol 10-20 mg IV bolus (less preferred due to bolus administration)
- Avoid venous vasodilators (may worsen intracranial pressure) 1
Important Caveats:
The safety of intensive BP lowering in large/severe ICH or those requiring surgical decompression is not established—use caution in these patients 1. BP variability during the first 24 hours independently predicts poor outcomes, so continuous smooth control matters as much as the target itself 1.
Acute Ischemic Stroke
For acute ischemic stroke NOT receiving reperfusion therapy, avoid antihypertensive treatment unless systolic BP >220 mmHg or diastolic BP >120 mmHg. 2
Management Algorithm for Ischemic Stroke:
If Patient is Eligible for IV Alteplase or Thrombectomy:
- Pre-treatment requirement: Lower BP to <185/110 mmHg BEFORE administering alteplase 2
- Post-treatment target: Maintain BP ≤180/105 mmHg for 24 hours after thrombolysis 2
Agents for BP control before/during thrombolysis:
- Labetalol 10-20 mg IV over 1-2 minutes, may repeat once
- Nicardipine 5 mg/h IV, titrate by 2.5 mg/h every 5-15 minutes (max 15 mg/h)
- Clevidipine 1-2 mg/h IV, titrate by doubling every 2-5 minutes (max 21 mg/h)
If BP cannot be controlled to <185/110 mmHg, do not administer alteplase 2.
If Patient is NOT Receiving Reperfusion Therapy:
- Permissive hypertension: Allow elevated BP unless >220/120 mmHg 2
- Rationale: Elevated BP may maintain cerebral perfusion to ischemic penumbra; aggressive lowering within 24 hours has not shown benefit and may worsen outcomes 3, 4, 5
Post-Thrombolysis Monitoring:
- Check BP every 15 minutes for 2 hours
- Then every 30 minutes for 6 hours
- Then hourly for 16 hours 2
If systolic BP 180-230 mmHg or diastolic 105-120 mmHg post-thrombolysis, use labetalol infusion (2-8 mg/min) or nicardipine 2.
Critical Pitfalls to Avoid:
Do not aggressively lower BP in acute ischemic stroke outside the thrombolysis context—this lacks evidence for benefit and may worsen cerebral perfusion 2, 4, 5
Do not lower systolic BP below 130 mmHg in ICH—this increases risk of poor outcomes 1
Do not use bolus dosing when possible—continuous infusions minimize dangerous BP variability 1
Do not delay imaging in transient symptoms—ICH can rarely present with transient deficits mimicking TIA, and starting antiplatelet therapy without imaging risks hematoma expansion 6
Correct hypotension immediately in any stroke subtype to maintain organ perfusion 2
Summary of Key Differences:
| Parameter | Ischemic Stroke | Hemorrhagic Stroke |
|---|---|---|
| Permissive hypertension? | Yes (if not receiving reperfusion) | No |
| Treatment threshold | >220/120 mmHg | >150 mmHg systolic |
| Target BP | <180/105 mmHg (if thrombolysis) | 130-150 mmHg systolic |
| Timing urgency | Within 24h (if thrombolysis) | Within 2 hours of onset |
| Avoid BP below | Variable | 130 mmHg systolic |
The fundamental principle: ICH requires immediate intensive BP lowering to prevent hematoma expansion, while ischemic stroke requires permissive hypertension to maintain penumbral perfusion—except when administering reperfusion therapy 1, 2.